HK1039353A1 - Group B streptococcus proteins, and their use Group B streptococcus proteins, and their use - Google Patents

Group B streptococcus proteins, and their use Group B streptococcus proteins, and their use

Info

Publication number
HK1039353A1
HK1039353A1 HK01108928A HK01108928A HK1039353A1 HK 1039353 A1 HK1039353 A1 HK 1039353A1 HK 01108928 A HK01108928 A HK 01108928A HK 01108928 A HK01108928 A HK 01108928A HK 1039353 A1 HK1039353 A1 HK 1039353A1
Authority
HK
Hong Kong
Prior art keywords
group
streptococcus proteins
streptococcus
proteins
genes
Prior art date
Application number
HK01108928A
Other languages
English (en)
Inventor
Martin John Glenton Hug Hughes
J D Santangelo J D Santangelo
Jonathan Douglas Lane Jon Lane
Paul Everest Paul Everest
Robert Feldman Robert Feldman
Joanne Christine Moore J Moore
Rebecca Kerry Wilson Re Wilson
Richard James Dobson Ri Dobson
Gordon Dougan Gordon Dougan
Original Assignee
Microscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9828352.6A external-priority patent/GB9828352D0/en
Priority claimed from GBGB9828350.0A external-priority patent/GB9828350D0/en
Priority claimed from GBGB9828354.2A external-priority patent/GB9828354D0/en
Priority claimed from GBGB9828345.0A external-priority patent/GB9828345D0/en
Priority claimed from GBGB9828355.9A external-priority patent/GB9828355D0/en
Priority claimed from GBGB9828353.4A external-priority patent/GB9828353D0/en
Priority claimed from GBGB9828356.7A external-priority patent/GB9828356D0/en
Priority claimed from GBGB9828357.5A external-priority patent/GB9828357D0/en
Priority claimed from GBGB9828349.2A external-priority patent/GB9828349D0/en
Priority claimed from GBGB9828359.1A external-priority patent/GB9828359D0/en
Priority claimed from GBGB9900082.0A external-priority patent/GB9900082D0/en
Priority claimed from GBGB9900085.3A external-priority patent/GB9900085D0/en
Priority claimed from GBGB9900086.1A external-priority patent/GB9900086D0/en
Priority claimed from GBGB9900084.6A external-priority patent/GB9900084D0/en
Priority claimed from GBGB9900083.8A external-priority patent/GB9900083D0/en
Priority claimed from GBGB9901922.6A external-priority patent/GB9901922D0/en
Priority claimed from GBGB9901916.8A external-priority patent/GB9901916D0/en
Application filed by Microscience Ltd filed Critical Microscience Ltd
Publication of HK1039353A1 publication Critical patent/HK1039353A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
HK01108928A 1998-12-22 2001-12-20 Group B streptococcus proteins, and their use Group B streptococcus proteins, and their use HK1039353A1 (en)

Applications Claiming Priority (18)

Application Number Priority Date Filing Date Title
GBGB9828349.2A GB9828349D0 (en) 1998-12-22 1998-12-22 Protein and compositions containing it
GBGB9828345.0A GB9828345D0 (en) 1998-12-22 1998-12-22 Protein and compositions containing it
GBGB9828355.9A GB9828355D0 (en) 1998-12-22 1998-12-22 Protein and compositions containing it
GBGB9828353.4A GB9828353D0 (en) 1998-12-22 1998-12-22 Protein and compositions containig it
GBGB9828356.7A GB9828356D0 (en) 1998-12-22 1998-12-22 Protein and compositions containing it
GBGB9828357.5A GB9828357D0 (en) 1998-12-22 1998-12-22 Protein and compositions containing it
GBGB9828352.6A GB9828352D0 (en) 1998-12-22 1998-12-22 Protein and compositions containing it
GBGB9828354.2A GB9828354D0 (en) 1998-12-22 1998-12-22 Protein and compositions containing it
GBGB9828359.1A GB9828359D0 (en) 1998-12-22 1998-12-22 Protein and compositions containing it
GBGB9828350.0A GB9828350D0 (en) 1998-12-22 1998-12-22 Protein and compositions containing it
GBGB9900085.3A GB9900085D0 (en) 1999-01-04 1999-01-04 Protein and compositions containing it
GBGB9900082.0A GB9900082D0 (en) 1999-01-04 1999-01-04 Protein and compositions containing it
GBGB9900086.1A GB9900086D0 (en) 1999-01-04 1999-01-04 Protein and compositions containing it
GBGB9900084.6A GB9900084D0 (en) 1999-01-04 1999-01-04 Protein and compositions containing it
GBGB9900083.8A GB9900083D0 (en) 1999-01-04 1999-01-04 Protein and compositions containing it
GBGB9901916.8A GB9901916D0 (en) 1999-01-28 1999-01-28 Protein and compositions containing it
GBGB9901922.6A GB9901922D0 (en) 1999-01-28 1999-01-28 Protein and compositions containing it
PCT/GB1999/004377 WO2000037646A2 (en) 1998-12-22 1999-12-22 Group b streptococcus proteins, and their use

Publications (1)

Publication Number Publication Date
HK1039353A1 true HK1039353A1 (en) 2002-04-19

Family

ID=27585888

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01108928A HK1039353A1 (en) 1998-12-22 2001-12-20 Group B streptococcus proteins, and their use Group B streptococcus proteins, and their use

Country Status (23)

Country Link
US (3) US6812021B1 (de)
EP (3) EP1757696A3 (de)
JP (1) JP2002533083A (de)
KR (3) KR100790653B1 (de)
CN (1) CN101066447A (de)
AP (1) AP1502A (de)
AT (1) ATE353367T1 (de)
AU (1) AU776735B2 (de)
CA (1) CA2354135A1 (de)
CY (1) CY1106559T1 (de)
CZ (1) CZ20012172A3 (de)
DK (1) DK1141308T3 (de)
EA (1) EA004444B1 (de)
ES (1) ES2281977T3 (de)
HK (1) HK1039353A1 (de)
HU (1) HUP0104825A3 (de)
NO (1) NO20013102L (de)
NZ (3) NZ535122A (de)
OA (1) OA11734A (de)
PL (1) PL201887B1 (de)
PT (1) PT1141308E (de)
SI (1) SI1141308T1 (de)
WO (1) WO2000037646A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1357045A (zh) * 1998-12-22 2002-07-03 微科学有限公司 外表面蛋白质及其基因和用途
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
GB0105922D0 (en) * 2001-03-09 2001-04-25 Microscience Ltd Genes and proteins, and their use
ES2281977T3 (es) * 1998-12-22 2007-10-01 Microscience Limited Proteinas de estreptococo del grupo b y su utilizacion.
WO2002018660A2 (en) 2000-08-31 2002-03-07 Mayo Foundation For Medical Education And Research Detection of varicella-zoster virus
GB0021977D0 (en) 2000-09-07 2000-10-25 Pyrosequencing Ab Method of sequencing DNA
US7691571B2 (en) 2001-01-31 2010-04-06 Mayo Foundation For Medical Education And Research Detection of bordetella
US7074598B2 (en) 2002-09-25 2006-07-11 Mayo Foundation For Medical Education And Research Detection of vancomycin-resistant enterococcus spp.
US7365176B2 (en) 2002-09-26 2008-04-29 Mayo Foundation For Medical Education And Research Detection of Epstein-Barr virus
AU2003298770A1 (en) * 2002-12-02 2004-06-23 Biosynexus Inc Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines
US7427475B2 (en) 2003-11-18 2008-09-23 Mayo Foundation For Medical Education And Research Detection of group B streptococcus
EP2104512A2 (de) * 2006-12-21 2009-09-30 Emergent Product Development UK Limited Streptokokkenproteine und deren verwendung bei der impfung
AU2013261006B2 (en) 2012-05-18 2016-07-14 Tata Consultancy Services Limited Method and system for determining and implementing a viable containment design of a data center
CN106822885B (zh) * 2017-02-16 2020-06-30 清华大学 肺炎链球菌疫苗

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5328996A (en) 1989-03-29 1994-07-12 University Of Florida Research Foundation, Inc. Bacterial plasmin receptors as fibrinolytic agents
WO1993014198A1 (en) 1992-01-08 1993-07-22 The Rockefeller University Multifunctional surface protein of streptococci
US6015889A (en) 1993-03-19 2000-01-18 Gunnar Lindahl Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
SG47049A1 (en) * 1993-03-19 1998-03-20 Gunnar Lindahl Protein rib a cell surface protein that confers immunity to manu strains of the group b strepto-ccus process for purification of the protein reagent kit
US5807978A (en) * 1995-06-07 1998-09-15 Kokolus; William J. Immunogenic peptides of prostate specific antigen
EP0942983B2 (de) 1996-10-31 2014-09-10 Human Genome Sciences, Inc. Streptococcus pneumoniae antigene und impfstoffe
US7196164B2 (en) 1997-07-08 2007-03-27 Human Genome Sciences, Inc. Secreted protein HHTLF25
US7115731B1 (en) * 1997-07-02 2006-10-03 sanofi pasteur limited/ sanofi pasteur limiteé Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US6800744B1 (en) 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US6380370B1 (en) 1997-08-14 2002-04-30 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
TR200002437T2 (tr) 1998-02-20 2000-11-21 Biochem Pharma Inc. B grubu streptococcus antijenleri.
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
WO2000003744A2 (en) 1998-07-14 2000-01-27 American Cyanamid Company Adjuvant and vaccine compositions containing monophosphoryl lipid a
WO2000006736A2 (en) 1998-07-27 2000-02-10 Microbial Technics Limited Nucleic acids and proteins from group b streptococcus
IL142831A0 (en) 1998-10-30 2002-03-10 Janssen Pharmaceutica Nv An unusual retrotransposon from the yeast candida albicans
AU1818200A (en) 1998-11-05 2000-05-22 Daniel Carucci Chromosome 2 sequence of the human malaria parasite (plasmodium falciparum) and proteins of said chromosome useful in anti-malarial vaccines and diagnostic reagents
ES2281977T3 (es) 1998-12-22 2007-10-01 Microscience Limited Proteinas de estreptococo del grupo b y su utilizacion.
CN1357045A (zh) 1998-12-22 2002-07-03 微科学有限公司 外表面蛋白质及其基因和用途
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
ATE327253T1 (de) 1999-04-09 2006-06-15 Heska Corp Proteine und nukleinsäuremoleküle des kopfes, des nervenkords, der tieferen darmabschnitte und des malpighi-gefässes des flohs und ihre verwendungen
US6605709B1 (en) 1999-04-09 2003-08-12 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Proteus mirabilis for diagnostics and therapeutics
GB9921125D0 (en) 1999-09-07 1999-11-10 Microbial Technics Limited Proteins
AU1478301A (en) 1999-11-09 2001-06-06 Glaxo Group Limited Staphylococcus epidermidis nucleic acids and proteins
AU2001254857A1 (en) 2000-04-11 2001-10-23 Institut Pasteur Listeria monocytogenes genome, polypeptides and uses
US6974667B2 (en) 2000-06-14 2005-12-13 Gene Logic, Inc. Gene expression profiles in liver cancer
MX357775B (es) 2000-10-27 2018-07-20 J Craig Venter Inst Inc Acidos nucleicos y proteinas de los grupos a y b de estreptococos.
WO2002077183A2 (en) 2001-03-21 2002-10-03 Elitra Pharmaceuticals, Inc. Identification of essential genes in microorganisms
GB0107658D0 (en) 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
GB0107661D0 (en) 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
US7384775B2 (en) 2001-04-16 2008-06-10 Wyeth Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
EP1528937B1 (de) 2001-06-05 2016-08-10 The Regents Of The University Of Michigan Nanoemulsionsvakzine
RU2323002C2 (ru) 2001-07-26 2008-04-27 Чирон Срл. Вакцины, содержащие алюминиевые адъюванты и гистидин
GB0210128D0 (en) 2002-05-02 2002-06-12 Chiron Spa Nucleic acids and proteins from streptococcus groups A & B
EP1551357B1 (de) 2002-09-13 2014-07-16 Novartis Vaccines and Diagnostics, Inc. Gruppe b streptokokken-vakzine
EP2289907A3 (de) 2003-05-07 2011-08-31 Intercell AG Streptococcus agalactiae-Antigene I + II
CA2537742C (en) 2003-09-15 2014-07-22 Chiron Corporation Immunogenic compositions for streptococcus agalactiae
EP1817432A2 (de) 2004-10-05 2007-08-15 Wyeth a Corporation of the State of Delaware Sonden-arrays zur detektion von mehreren stämmen verschiedener arten
CA2591510A1 (en) 2004-12-22 2006-06-29 Novartis Vaccines And Diagnostics, Inc. Group b streptococcus

Also Published As

Publication number Publication date
WO2000037646A3 (en) 2000-10-26
EA004444B1 (ru) 2004-04-29
AP2001002189A0 (en) 2001-06-30
EP1757696A3 (de) 2008-10-29
EP1141308A2 (de) 2001-10-10
HUP0104825A3 (en) 2008-04-28
US20090274717A1 (en) 2009-11-05
EA200100700A1 (ru) 2001-12-24
NZ535122A (en) 2006-04-28
PL201887B1 (pl) 2009-05-29
KR20070101197A (ko) 2007-10-16
ATE353367T1 (de) 2007-02-15
JP2002533083A (ja) 2002-10-08
US7419672B2 (en) 2008-09-02
AP1502A (en) 2005-12-20
KR100790653B1 (ko) 2007-12-31
OA11734A (en) 2005-05-12
NZ526879A (en) 2004-12-24
AU776735B2 (en) 2004-09-23
AU1878000A (en) 2000-07-12
KR20010089844A (ko) 2001-10-11
DK1141308T3 (da) 2007-06-04
NO20013102L (no) 2001-08-10
NZ512297A (en) 2003-12-19
PL349320A1 (en) 2002-07-15
EP1141308B1 (de) 2007-02-07
ES2281977T3 (es) 2007-10-01
EP1757696A2 (de) 2007-02-28
CZ20012172A3 (cs) 2001-11-14
US20080181908A1 (en) 2008-07-31
KR20080050550A (ko) 2008-06-09
CA2354135A1 (en) 2000-06-29
HUP0104825A2 (hu) 2002-04-29
EP2105504A3 (de) 2010-01-06
SI1141308T1 (sl) 2007-08-31
PT1141308E (pt) 2007-05-31
CN101066447A (zh) 2007-11-07
WO2000037646A2 (en) 2000-06-29
US6812021B1 (en) 2004-11-02
CY1106559T1 (el) 2012-01-25
NO20013102D0 (no) 2001-06-21
EP2105504A2 (de) 2009-09-30

Similar Documents

Publication Publication Date Title
PL349320A1 (en) Genes and proteins, and their use
WO2002022168A3 (en) Vaccine against streptococcus pneumoniae
DE69929232D1 (de) Virusähnliche partikel zur induktion von autoantikörpern
DE69932717D1 (de) Methoden und produkte zur induzierung mukosaler immunität
MXPA03000103A (es) Antigenos de streptococcus.
WO2002034773A3 (en) Streptococcal genes
WO2002075507A3 (en) Anti-bacterial vaccine compositions
WO2000061724A3 (en) Anti-bacterial vaccine compositions
WO2000058475A3 (en) Streptococcus pneumoniae antigens
PT1154791E (pt) Composições e métodos de vacinação contra neisseria
WO2001055111A8 (en) Biaryl compounds, their preparation and their use in therapy
NZ511366A (en) Virulence genes and proteins, and their use
AU5628796A (en) Coccidiosis poultry vaccine
WO2000037490A3 (en) Outer surface proteins, their genes, and their use
EP1905834A3 (de) Virulenzgene, Proteine und deren Verwendung
AU6956198A (en) Serogroup-specific nucleotide sequences in the molecular typing of bacterial isolates and the preparation of vaccines thereto
AP1679A (en) Outer surface proteins, their genes, and their use.
CA2285633A1 (en) Bacterial plasmids
WO2003044047A3 (en) Virulence proteins of the genus yersinia and uses thereof
GB9810084D0 (en) Proteins
ZA200002615B (en) Live attenuated bacteria for use in a vaccine.
NZ514027A (en) Cloning and expression of haemophilus somnus transferrin-binding proteins
AU1321988A (en) The cloning of malaria-specific dna sequences: isolation of the gene for the 140 kd protein
WO2000029433A3 (en) 12-25-kda bacterial proteins and their 116-58 kda polymers for use e.g. in anti-tumor vaccines
WO2001021655A3 (en) Virulence gene and protein, and their use